Point72 Asset Management’s Mersana Therapeutics MRSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-682
| Closed | -$21.6K | – | 1816 |
|
|
2023
Q3 | $21.6K | Buy |
682
+543
| +391% | +$17.2K | ﹤0.01% | 1596 |
|
|
2023
Q2 | $11.4K | Buy |
+139
| New | +$11.4K | ﹤0.01% | 1358 |
|
|
2022
Q1 | – | Sell |
-32,724
| Closed | -$5.09M | – | 1199 |
|
|
2021
Q4 | $5.09M | Buy |
+32,724
| New | +$5.09M | 0.02% | 623 |
|
|
2021
Q3 | – | Sell |
-1,076
| Closed | -$365K | – | 1101 |
|
|
2021
Q2 | $365K | Sell |
1,076
-40,648
| -97% | -$13.8M | ﹤0.01% | 826 |
|
|
2021
Q1 | $16.9M | Buy |
41,724
+4,844
| +13% | +$1.96M | 0.08% | 289 |
|
|
2020
Q4 | $24.5M | Sell |
36,880
-4,877
| -12% | -$3.24M | 0.12% | 224 |
|
|
2020
Q3 | $19.4M | Buy |
+41,757
| New | +$19.4M | 0.1% | 267 |
|
|
2020
Q1 | – | Sell |
-6,000
| Closed | -$860K | – | 929 |
|
|
2019
Q4 | $860K | Sell |
6,000
-13,800
| -70% | -$1.98M | ﹤0.01% | 689 |
|
|
2019
Q3 | $782K | Sell |
19,800
-6,800
| -26% | -$269K | ﹤0.01% | 668 |
|
|
2019
Q2 | $2.69M | Sell |
26,600
-34,775
| -57% | -$3.52M | 0.01% | 529 |
|
|
2019
Q1 | $8.07M | Buy |
61,375
+39,375
| +179% | +$5.18M | 0.04% | 390 |
|
|
2018
Q4 | $2.24M | Buy |
+22,000
| New | +$2.24M | 0.01% | 612 |
|
|
2018
Q3 | – | Sell |
-5,672
| Closed | -$2.53M | – | 970 |
|
|
2018
Q2 | $2.53M | Sell |
5,672
-1,128
| -17% | -$504K | 0.01% | 579 |
|
|
2018
Q1 | $2.68M | Buy |
+6,800
| New | +$2.68M | 0.01% | 563 |
|